OTC

Strength

1; 10; 5 mg/5mL; mg/5mL; mg/5mL

NDC

69367033416

Classification

Generic

Dosage Form

SYRUP

Route

ORAL

Last Updated

4/22/2026

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

7/29/2021

Pharmacological Classes

Adrenergic alpha1-Agonists
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-1 Adrenergic Agonist

Price History

1W

0.0%

1M

+0.1%

3M

0.0%

6M

-0.6%

1Y

+0.3%

3Y

-3.5%

5Y

N/A

All

-23.3%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.